Lantheus
LNTH
Workday
WDAY
Hutchmed (China)
HCM
YETI Holdings
YETI
DexCom
DXCM
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -20.32%54.1M | 119.08%238.8M | 58.05%89.3M | 16.87%87.3M | 63.69%-5.7M | 1,144.62%67.9M | 108.41%109M | 77.67%56.5M | 279.19%74.7M | 17.37%-15.7M |
Net income from continuing operations | 146.85%35.3M | 35.56%115.9M | -41.86%10M | 93.06%47.3M | 107.98%44.3M | -36.44%14.3M | 11.62%85.5M | 142.25%17.2M | -7.55%24.5M | -9.75%21.3M |
Operating gains losses | -81.82%200K | 1,175.00%5.1M | 71.43%1.2M | 0.00%1.2M | 14.29%1.6M | 137.93%1.1M | 115.38%400K | 200.00%700K | 300.00%1.2M | 333.33%1.4M |
Depreciation and amortization | -32.32%11.1M | 5.92%66.2M | 3.66%17M | 3.16%16.3M | 6.45%16.5M | 10.81%16.4M | 3.31%62.5M | 5.13%16.4M | 6.04%15.8M | 4.73%15.5M |
Deferred tax | 82.35%-600K | -49.31%-21.5M | 62.34%-2.9M | -27.94%-8.7M | -750.00%-6.5M | -277.78%-3.4M | -311.43%-14.4M | -45.28%-7.7M | -58.14%-6.8M | -60.00%1M |
Other non cash items | 0.00%300K | 11.11%1M | 250.00%700K | --0 | --0 | -40.00%300K | -30.77%900K | -66.67%200K | -50.00%100K | 120.00%100K |
Change In working capital | -96.23%1.3M | 216.38%40.5M | 78.97%48.5M | -38.48%24.3M | -15.37%-66.8M | 179.31%34.5M | 64.16%-34.8M | 243.04%27.1M | 299.49%39.5M | 5.08%-57.9M |
-Change in receivables | 26.56%62.9M | -22.94%8.4M | 163.01%4.6M | -15.18%16.2M | -127.47%-62.1M | 88.26%49.7M | 161.24%10.9M | -1.39%-7.3M | 2,222.22%19.1M | 34.38%-27.3M |
-Change in inventory | -42.47%-20.8M | 59.80%-8M | -123.94%-3.4M | -3.85%10M | --0 | 59.56%-14.6M | 79.76%-19.9M | 152.59%14.2M | 143.70%10.4M | 56.25%-8.4M |
-Change in payables and accrued expense | -289.47%-10.8M | 134.52%6.8M | 1,042.86%24M | -336.00%-10.9M | -4,100.00%-12M | 129.08%5.7M | -161.18%-19.7M | -91.76%2.1M | 72.53%-2.5M | -98.76%300K |
-Change in other current assets | 78.69%-1.3M | -133.33%-7.7M | 38.46%-800K | -2,900.00%-3M | 29.41%2.2M | -69.44%-6.1M | -353.85%-3.3M | -119.12%-1.3M | 96.77%-100K | 206.25%1.7M |
-Change in other current liabilities | -14,250.00%-28.7M | 1,564.29%41M | 24.23%24.1M | -4.76%12M | 121.07%5.1M | 98.11%-200K | 80.69%-2.8M | 97.96%19.4M | -26.32%12.6M | -6.14%-24.2M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -20.32%54.1M | 119.08%238.8M | 58.05%89.3M | 16.87%87.3M | 63.69%-5.7M | 1,144.62%67.9M | 108.41%109M | 77.67%56.5M | 279.19%74.7M | 17.37%-15.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -112.50%-11.9M | -12.11%-47.2M | -30.41%-19.3M | -2.52%-12.2M | 4.72%-10.1M | -16.67%-5.6M | 23.32%-42.1M | 19.57%-14.8M | -11.21%-11.9M | 29.33%-10.6M |
Capital expenditure reported | -108.77%-11.9M | 0.42%-47.4M | -27.63%-19.4M | -2.52%-12.2M | 4.72%-10.1M | 42.42%-5.7M | 12.98%-47.6M | 15.56%-15.2M | -11.21%-11.9M | 29.33%-10.6M |
Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other investing changes | ---- | -96.36%200K | -75.00%100K | --0 | --0 | -98.04%100K | --5.5M | --400K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -112.50%-11.9M | -12.11%-47.2M | -30.41%-19.3M | -2.52%-12.2M | 4.72%-10.1M | -16.67%-5.6M | 23.32%-42.1M | 19.57%-14.8M | -11.21%-11.9M | 29.33%-10.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -15.93%-13.1M | 5.74%-46M | 72.96%-5.3M | -2.20%-9.3M | -109.38%-20.1M | -7.62%-11.3M | 32.22%-48.8M | -3.70%-19.6M | 35.00%-9.1M | -11.63%-9.6M |
Net issuance payments of debt | 0.00%-200K | 18.18%-900K | 0.00%-200K | 33.33%-200K | 40.00%-300K | -100.00%-200K | -57.14%-1.1M | 33.33%-200K | 0.00%-300K | ---500K |
Net common stock issuance | 300.00%1.6M | 68.49%-2.3M | 156.52%5.2M | 11.11%1M | -2,325.00%-8.9M | -33.33%400K | 77.88%-7.3M | 4.17%-9.2M | 120.00%900K | 0.00%400K |
Cash dividends paid | -5.00%-10.5M | -4.72%-39.9M | -5.26%-10M | -3.13%-9.9M | -5.26%-10M | -5.26%-10M | -4.38%-38.1M | -4.40%-9.5M | -5.49%-9.6M | -4.40%-9.5M |
Net other financing activities | -166.67%-4M | -26.09%-2.9M | 57.14%-300K | -100.00%-200K | ---900K | 0.00%-1.5M | -27.78%-2.3M | -800.00%-700K | 0.00%-100K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -15.93%-13.1M | 5.74%-46M | 72.96%-5.3M | -2.20%-9.3M | -109.38%-20.1M | -7.62%-11.3M | 32.22%-48.8M | -3.70%-19.6M | 35.00%-9.1M | -11.63%-9.6M |
Net cash flow | ||||||||||
Beginning cash position | 93.33%309.9M | 9.42%160.3M | 72.31%243.3M | 100.90%179.2M | 72.53%216.7M | 9.42%160.3M | -35.60%146.5M | -8.84%141.2M | -45.64%89.2M | -39.41%125.6M |
Current changes in cash | -42.94%29.1M | 704.42%145.6M | 192.76%64.7M | 22.53%65.8M | 0.00%-35.9M | 333.94%51M | 124.26%18.1M | 501.82%22.1M | 1,174.00%53.7M | 15.73%-35.9M |
Effect of exchange rate changes | -114.81%-800K | 193.02%4M | 163.33%1.9M | 0.00%-1.7M | -220.00%-1.6M | 500.00%5.4M | 32.81%-4.3M | -3.45%-3M | 59.52%-1.7M | 16.67%-500K |
End cash Position | 56.07%338.2M | 93.33%309.9M | 93.33%309.9M | 72.31%243.3M | 100.90%179.2M | 72.53%216.7M | 9.42%160.3M | 9.42%160.3M | -8.84%141.2M | -45.64%89.2M |
Free cash flow | -32.15%42.2M | 211.73%191.4M | 69.25%69.9M | 19.59%75.1M | 39.92%-15.8M | 479.27%62.2M | 2,658.33%61.4M | 199.28%41.3M | 597.78%62.8M | 22.65%-26.3M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |